Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Gynecologic Oncology|September 16, 2022
HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapyTenley R Klc, Sharon Wu, Annelise M Wilhite, et al.
Gynecologic Oncology|November 13, 2025
Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinomaRachel L Furuya, Whitney Grither, Mark G Evans, et al.
JCO Precision Oncology|April 28, 2025
Association of Androgen Receptor Expression With Tumor Immune Landscape and Treatment Outcomes of Patients With Breast CancerPriya Jayachandran, Sachin K Deshmukh, Sharon Wu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 3, 2023
The Genomic Landscape of Vulvar Squamous Cell CarcinomaLogan Corey, John J Wallbillich, Sharon Wu, et al.
Cell Reports|August 25, 2021
Evaluating the impact of age on immune checkpoint therapy biomarkersRossin Erbe, Zheyu Wang, Sharon Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic SubtypesJustin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Inhibition of PIM kinase in tumor associated macrophages suppresses inflammasome activation and sensitizes prostate cancer to immunotherapyAmber N Clements, Andrea L Casillas, Caitlyn E Flores, et al.
Cancer Immunology Research|February 21, 2025
Inhibition of PIM Kinase in Tumor-Associated Macrophages Suppresses Inflammasome Activation and Sensitizes Prostate Cancer to ImmunotherapyAmber N Clements, Andrea L Casillas, Caitlyn E Flores, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanismsElena Lomonosova, Megan Loeb, Kevin Rodriguez, et al.
Pageof 8